Anatolia Geneworks is a global biotech company designing, developing, manufacturing Real-Time PCR kits, automated Nucleic Acid Extraction instruments and kits with ISO9001, ISO13485 and IVD-CE.
Founded as a start-up in 2010, Anatolia Tanı AŞ (with brand name Anatolia Geneworks), is one of the very few companies in the world, with the ability to create turnkey solutions for Real-Time PCR applications with IVD CE certificated List A and List B pathogen detection kits including HBV, HCV, HDV, CMV and HIV-1.
Anatolia Geneworks expands its product portfolio continuously and the newly launched multiplex Respiratory, Sexually Transmitted Diseases, Meningitis and CNS panel kits made a tremendous impact among users.
Anatolia Geneworks has taken its expertise in the detection of respiratory pathogens one step further by launching Novel Coronavirus (2019-nCoV or SARS-CoV-2) Detection Kits. After following up the news since mid-December, when the COVID-19 outbreak was just beginning, the company completed its R&D within a few weeks after the World Health Organization (WHO) published the genetic codes of the virus and launched its Bosphore Novel Coronavirus (2019-nCoV) Detection Kit in February 2020. To date, these kits have been used in testing millions of people in many countries in Europe, Asia, Americas, Africa and the Middle East. As the total number of kits used in several countries is over 5 million, and inquiries from more than 50 countries is surpassing millions of tests, Anatolia is continuing its production at full capacity to fulfill these demands.
The company provides world-class molecular diagnostic products used in more than 80 hospitals and laboratories in Turkey, and exported to more than 50 countries in Europe, Asia, America and Africa.